Medicare D prescription drug plan should not prevent pharmacies from telling customers when they could pay less for a drug by paying cash, the Centers for Medicare & Medicaid Services told plan sponsors yesterday.
News
Latest
House Speaker Paul Ryan (R-WI) yesterday discussed a potential compromise on the Creating and Restoring Equal Access to Equivalent Samples Act (S. 974/H.R. 2212), as part of congressional action to address high drug prices.
The Ebola outbreak in the Democratic Republic of Congo has spread from a remote area to a city of 1.2 million, the World Health Organization reported yesterday, after one case was confirmed in the city of Mbandaka.
An issue brief released this week by The Trust for America’s Health and Well Being Trust highlights actions that the health care system – including hospitals and health systems – can take to help address issues like drug overdoses, alcohol-related deaths and suicides.
A Teachable Moment – a feature-length documentary that shares stories from four stroke survivors, as well as insights from experts that outline tangible measures to reduce risk factors for the neurological disorder – premiered last night.
U.S. births declined for the third year in a row in 2017 to 3.85 million, the fewest in 30 years, according to a new report by the Centers for Disease Control and Prevention.
The House Energy and Commerce Committee today approved more than 20 bills to address the opioid crisis.
The House of Representatives last night voted 347-70 to approve bipartisan legislation to streamline and consolidate the Department of Veterans Affairs’ community care programs into a permanent Veterans Community Care Program.
The Senate Appropriations Subcommittee on Financial Services and General Government today held a hearing on the Federal Communications Commission’s and Federal Trade Commission’s budget request for fiscal year 2019.
The Physician-Focused Payment Model Technical Advisory Committee recently submitted four recommendations to the Department of Health and Human Services, including a
The Food and Drug Administration today announced new efforts to spotlight situations where drugmakers may be pursuing “gaming tactics” to delay generic competition.
The AHA and seven other national hospital organizations yesterday voiced strong support for legislation that would allow states to receive federal matching funds for services provided to a Medicaid beneficiary with a substance use disorder in an Institution for Mental Disease.
Sens. Mike Lee (R-UT), Orrin Hatch (R-UT), Thom Tillis (R-NC) and Charles Grassley (R-IA) yesterday introduced the Standard Merger and Acquisition Reviews Through Equal Rules Act (S. 2847), AHA-supported legislation that would standardize the merger review process for the two federal antitrust agencies.
The Food and Drug Administration today issued a final order exempting manufacturers from FDA premarket notification requirements for certain N95 respirators, disposable devices used to protect patients and health care providers from infection.
An estimated 46,041 Americans died from opioid overdoses between October 2016 and October 2017, a 15% increase from the prior 12-month period.
The Centers for Medicare & Medicaid Services today updated the Parts B and D drug spending dashboards with 2016 information.
The Food and Drug Administration Friday issued final guidance clarifying that an organization may operate both a compounding pharmacy and outsourcing facility at the same address or general location if they are completely segregated by clearly identified boundaries.
More than 60 patients groups yesterday urged Congress to protect the 340B drug savings program.
The Centers for Medicare & Medicaid Services has approved a five-year agreement with Maryland to expand the state’s all-payer model from focusing on hospitals to also incentivizing other providers to address the total cost of care beginning in 2019.
The Senate Health, Education, Labor and Pensions Committee today held the second in a series of hearings examining the 340B drug savings program.